SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Omkar Pharmachem - Quaterly Results

13 Aug 2025 Evaluate
Revenue reduced marginally to stand at Rs. 1.35 millions during the quarter ended June 2025. The figure stood at Rs. 1.35 millions during the year-ago period.The Net Profit of the company slipped to Rs. 0.27 millions from Rs. 0.49 millions, a decline of -44.90% on QoQ basis.Operating Profit reported a sharp decline to 0.37 millions from 0.50 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1.35 1.35 0.00 1.35 1.35 0.00 5.40 5.40 0.00
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.03 -33.33
PBIDT 0.37 0.50 -26.00 0.37 0.50 -26.00 2.92 2.87 1.74
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.17 0.29 -41.38
PBDT 0.37 0.50 -26.00 0.37 0.50 -26.00 2.75 2.58 6.59
Depreciation 0.01 0.01 0.00 0.01 0.01 0.00 0.05 0.05 0.00
PBT 0.36 0.49 -26.53 0.36 0.49 -26.53 2.70 2.53 6.72
TAX 0.09 0.00 0.00 0.09 0.00 0.00 0.69 0.64 7.81
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.27 0.49 -44.90 0.27 0.49 -44.90 2.01 1.89 6.35
Equity 100.84 100.84 0.00 100.84 100.84 0.00 100.84 100.84 0.00
PBIDTM(%) 27.41 37.04 -26.00 27.41 37.04 -26.00 54.07 53.15 1.74

Omkar Pharmachem Share Price

29.50 0.00 (0.00%)
16-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×